Order Article Reprints

Kariyama K, Nouso K, Toyoda H, Tada T, Hiraoka A, Tsuji K, Itobayashi E, Ishikawa T, Wakuta A, Oonishi A, et al. Utility of FIB4-T as a Prognostic Factor for Hepatocellular Carcinoma. Cancers. 2019; 11(2):203. https://doi.org/10.3390/cancers11020203

Kariyama, Kazuya, Kazuhiro Nouso, Hidenori Toyoda, Toshifumi Tada, Atsushi Hiraoka, Kunihiko Tsuji, Ei Itobayashi, Toru Ishikawa, Akiko Wakuta, Ayano Oonishi, and et al. 2019. "Utility of FIB4-T as a Prognostic Factor for Hepatocellular Carcinoma" Cancers 11, no. 2: 203. https://doi.org/10.3390/cancers11020203

Kariyama, K., Nouso, K., Toyoda, H., Tada, T., Hiraoka, A., Tsuji, K., Itobayashi, E., Ishikawa, T., Wakuta, A., Oonishi, A., Kumada, T., & Kudo, M., on behalf of the Real-Life Practice Experts for HCC (RELPEC) Study Group and HCC 48 Group. (2019). Utility of FIB4-T as a Prognostic Factor for Hepatocellular Carcinoma. Cancers, 11(2), 203. https://doi.org/10.3390/cancers11020203